JPRN-UMIN000048073尚未招募未知
A Phase II Single-Arm Study to Evaluate the Feasibility of Preoperative Rehabilitation and Nutrition Intervention in Patients Undergoing Resection for Hepato-Pancreato-Biliary Surgeries. - RENUH trial
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The patients who have uncontrollable infection, diabetes, cerebral infarction, and myocardial infarction.
研究者
相似试验
招募中
不适用
A Phase II Single-Arm Study to Evaluate the Feasibility of Preoperative Rehabilitation and Nutrition Intervention in Patients Undergoing Neoadjuvant Chemotherapy for Esophageal Canceresophageal cancerJPRN-UMIN000045479Keio University33
招募中
不适用
Clinical study to determine the appropriateness of a starting dose of 160 mg/day of lazertinib in patients with EGFR T790M-positive non-small cell lung cancerNeoplasmsKCT0008332Samsung Medical Center117
尚未招募
2 期
Dose-Dense ABVD Study: An accelerated delivery of Adriamycin, Bleomycin, Vinblastin and Dacarbazine for patients with Hodgkin LymphomaEarly Stage Unfavourable Hodgkin LymphomaAdvanced Stage Hodgkin LymphomaCancer - Hodgkin'sACTRN12612000137897Queensland Health31
进行中（未招募）
1 期
A Study of Avapritinib in Pediatric Patients with Solid Tumors Dependent on KIT or PDGFRA SignalingSolid Tumors Dependent on KIT or PDGFRA SignalingMedDRA version: 21.1Level: LLTClassification code 10065252Term: Solid tumorSystem Organ Class: 100000004864EUCTR2020-005234-15-ITBLUEPRINT MEDICINES CORPORATIO37
进行中（未招募）
1 期
A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA SignalingCTIS2023-508617-16-00Blueprint Medicines Corp.37